This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arditi, M Articles by Kim, K S Search for Related Content PubMed PubMed Citation Articles by Arditi, M Articles by Kim, K S

 Previous Article  |  Next Article 

Infection and Immunity, September 1994, p. 3930-3936, Vol. 62, No. 9
0019-9567/1994/$04.00+0     DOI:

research-article

Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.

Division of Infectious Diseases, Children's Hospital Los Angeles, University of Southern California School of Medicine 90027.

ABSTRACT

Bactericidal/permeability-increasing protein (BPI), a human neutrophil granule protein, has been shown to bind lipopolysaccharide (LPS) and neutralize LPS-mediated cytokine production in adherent monocytes and the whole-blood system. In this study we investigated the ability of recombinant human BPI (rBPI) to inhibit LPS-induced vascular endothelial cell (EC) injury and activation. rBPI inhibited significantly both rough and smooth LPS-mediated injury for cultured bovine brain microvessel ECs, as measured by lactic dehydrogenase release, and blocked the LPS-induced interleukin-6 (IL-6) release from human umbilical vein ECs in a dose-dependent manner. BPI was able to inhibit LPS-mediated EC injury or activation whether it was added before or at the same time with LPS, but delaying the time of addition of rBPI resulted only in a partial inhibition. BPI also inhibited LPS-induced tumor necrosis factor alpha, IL-1 beta, and IL-6 release from human whole blood. This inhibition of tumor necrosis factor alpha, IL-1 beta, and IL-6 release from whole blood was maximal when BPI was premixed with LPS before addition to blood and was partial when BPI was added simultaneously with LPS, but no inhibition was observed when the addition of rBPI was delayed for 5 min. These findings suggest that rBPI is a potent inhibitor of LPS-mediated responses in ECs and whole blood and underscore the potential use of BPI in treatment or prevention of endotoxic shock. In contrast, the anti-lipid A monoclonal antibodies HA-1A and E5 were ineffective in inhibiting LPS-mediated EC injury and activation as well as LPS-induced cytokine release in whole blood.

This article has been cited by other articles:

• Horton, J. W., Maass, D. L., White, D. J., Minei, J. P. (2007). Bactericidal/permeability increasing protein attenuates the myocardial inflammation/dysfunction that occurs with burn complicated by subsequent infection. J. Appl. Physiol. 103: 948-958 [Abstract] [Full Text]  
• Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
• Levy, O. (2000). A Neutrophil-Derived Anti-Infective Molecule: Bactericidal/Permeability-Increasing Protein. Antimicrob. Agents Chemother. 44: 2925-2931 [Full Text]  
• Hiki, N., Berger, D., Dentener, M. A., Mimura, Y., Buurman, W. A., Prigl, C., Seidelmann, M., Tsuji, E., Kaminishi, M., Beger, H. G. (1999). Changes in Endotoxin-Binding Proteins during Major Elective Surgery: Important Role for Soluble CD14 in Regulation of Biological Activity of Systemic Endotoxin. CVI 6: 844-850 [Abstract] [Full Text]  
• Dixon, G. L. J., Heyderman, R. S., Kotovicz, K., Jack, D. L., Andersen, S. R., Vogel, U., Frosch, M., Klein, N. (1999). Endothelial Adhesion Molecule Expression and Its Inhibition by Recombinant Bactericidal/Permeability-Increasing Protein Are Influenced by the Capsulation and Lipooligosaccharide Structure of Neisseria meningitidis. Infect. Immun. 67: 5626-5633 [Abstract] [Full Text]  
• Arditi, M., Jin Zhou, , Sheng He Huang, (1996). Antibiotic induced bacterial killing activates vascular endothelial cells and whole blood cells: Role of free lipopolysaccharide and soluble CD14. Innate Immunity 3: 179-185 [Abstract]